Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGylated recombinant human growth hormone in short children born small for gestational age
CTR20160666Phase 2Active
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peg-somatropin in growth disorder, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Sep 2016; status: active.
02
Drugs
peg-somatropin
03
Conditions
growth disorder
Beyond the preview
Go deeper on CTR20160666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160666.